期刊
JOURNAL OF MOLECULAR EVOLUTION
卷 81, 期 5-6, 页码 179-185出版社
SPRINGER
DOI: 10.1007/s00239-015-9703-y
关键词
AIB1; Aptamer; SELEX; Cancer
资金
- National Basic Research Program of China [2013CB933703]
- National Science Foundation of China [21325522, 21205100, 21275122, 21521004]
- National Science Fund for Fostering Talents of Basic Science [J1310024]
- Fundamental Research Funds for the Central Universities [20720150141]
- National Instrumentation Program [2011YQ03012412]
Amplified in breast cancer 1 (AIB1), also known as steroid receptor coactivator 3 (SRC-3), is a transcriptional coactivator that interacts with nuclear receptors and other transcription factors to enhance their effects on target gene transcription. AIB1, which acts as a major oncogene, is highly expressed in many human cancers, and has been demonstrated to be a key regulator for tumor initiation, progression, metastasis, invasion, and survival. Recruitment of the transcriptional factor CBP/p300 by CBP/p300-interaction domain (CID) of AIB1 is essential for its transcriptional activation function. In this research, we isolated a DNA aptamer AY-3 that binds to AIB1-CID from a random oligonucleotide library using in vitro screening technology-Systematic Evolution of Ligands by EXponential enrichment (SELEX). The binding affinity of the aptamer to AIB1-CID fusion protein is in the nanomolar range. More importantly, the aptamer was found to disrupt in the interaction between p300 and AIB1. This aptamer has great potential to serve as a therapeutic agent for cancer by inhibiting the coactivation of AIB1.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据